As a follow up to my last post about the three posters that appeared at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium meeting I am going to share with you a video interview with Dr. Chadi Nabhan. Dr. Nabhan talks about his presentation about the phase III results of the Provenge IMPACT study.
The study results suggest that treating advanced prostate cancer with Provenge may increase survival even longer than previously believed. He also discusses a few of the promising research and treatments that are development.
The interview was produce by my colleague, Andrew Shore at Patient Power. The video can be seen at:
Andrew has promised some additional video in the next few days.
Good news for men battling advanced prostate cancer.
Joel T Nowak, M.A., M.S.W.